Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

about

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

Item

http://www.wikidata.org/entity/Q36291435

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@ast

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@en

type

Item

label

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@ast

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@en

prefLabel

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@ast

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@en

P1476

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation.

@en

P2093

Eun-Kyung Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Sik Na

http://www.w3.org/2001/XMLSchema#string

Jeong-Eun Kwon

http://www.w3.org/2001/XMLSchema#string

Jeong-Hee Jeong

http://www.w3.org/2001/XMLSchema#string

JooYeon Jhun

http://www.w3.org/2001/XMLSchema#string

Jun-Ki Min

http://www.w3.org/2001/XMLSchema#string

KyungAh Jung

http://www.w3.org/2001/XMLSchema#string

Mi-La Cho

http://www.w3.org/2001/XMLSchema#string

Se-Young Kim

http://www.w3.org/2001/XMLSchema#string

Seung Hoon Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing

VCAM-1 is critical in atherosclerosis.

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis.

Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.

CD4+ T cells in atherosclerosis.

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis.

Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.

Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells.

Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.

Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction.

P304

e0171674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0171674

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28241014

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5328247

http://www.w3.org/2001/XMLSchema#string